SECAUCUS, NJ / ACCESSWIRE / October 17, 2022 / Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, recently announced the launch of a new obstetrics ...
(RTTNews) - Quest Diagnostics (DGX) announced the launch of a new obstetrics laboratory test panel designed to enable physicians to screen all eligible pregnant people for hepatitis C with other ...
Quest Diagnostics launched a new obstetrics test panel that is designed to allow physicians to easily test pregnant people for hepatitis C. The test panel screens for hepatitis C alongside other ...
Quest Diagnostics launched an obstetrics test panel for screening pregnant people for hepatitis C. The panel is designed to facilitate easy and reliable screening for hepatitis C with other lab tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results